Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Neural Stimulation in Individuals With Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age = 18-64~* Diagnosed with schizophrenia or schizoaffective disorder~* Having current (in the past week) or recent (in the past month) paranoia~Exclusion Criteria:~* Presence or history of a pervasive developmental disorder or mental retardation as defined by IQ \< 70~* Presence or history of neurological or medical disorders that contraindicate neural stimulation (e.g. presence or history of epilepsy, seizures, etc.)~* Demonstrating sensory limitations, including uncorrectable visual or hearing impairments that interfere with assessment~* History of electroconvulsive therapy~* Lack of proficiency in English~* Substance use disorder not in remission in the past 6 months~* Any implanted devices such as pace maker, neurostimulator~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Active anodal tDCS first, then Sham tDCS (Type: EXPERIMENTAL): Active anodal tDCS (40 minutes; divided into two 20-minutes sessions) followed by behavioral testing; Washout (about 1 week); sham stimulation (40 minutes; divided into two 20-minutes sessions) followed by behavioral testing.
- Sham tDCS first, then Active anodal tDCS (Type: SHAM_COMPARATOR): Sham tDCS (40 minutes; divided into two 20-minutes sessions) followed by behavioral testing; Washout (about 1 week); Active anodal tDCS (40 minutes; divided into two 20-minutes sessions) followed by behavioral testing Intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).